Search Results
prognostic indicator in patients with lung cancer Respiration 71 170 3 . 20. D Buergy
174 176 J.S. Lopez-Gonzalez, H. Prado-Garcia, D. Aguilar-Cazares, J.A. Molina-Guarneros, J. Morales-Fuentes, J.J. Mandoki, Lung Cancer 43 (2004) 275
. PC Chen XM Zhou QX Chen 2008 Sleeve resection for lung cancer: a report of 82 cases
241 248 Griffey, S. M., Kraegel, S. A. and Madwell, B. R. (1999): Proliferation indices in spontaneous ca-nine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB
References 1 Moldvay J, Rokszin G, Abonyi-Tóth Z, et al. Lung cancer drug therapy in Hungary – 3-year experience. Onco Targets Ther. 2015; 8: 1031
oncology. [A PET/CT és szerepe az onkológiában.] Orv Tud Ért. 2007; 80: 96–105. [Hungarian] 4 Shim SS, Lee KS, Kim BT, et al. Non-small cell lung cancer: prospective comparison of
adenocarcinoma: a systematic review. Hepatobiliary Pancreat Dis Int. 2014; 13: 474–481. 9 Jafri SH, Shi R, Mills G. Advance lung cancer inflammation index (ALI) at diagnosis is a
Goldkorn T, Filosto S, Chung S. Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and
., 2006, 41 (7), 694–698. 15 Gould, M. K., Fletcher, J., Iannettoni, M. D., et al.: Evaluation of patients with pulmonary nodules: when is it lung cancer? ACCP
. 3 Albanes, D., Heinonen, O. P., Taylor, P. R., et al.: Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention
